Company intelligence / Profile preview

Caprico Biotechnologies

Norcross, Georgia, United Statescapricobio.com ↗

Ownership: Private
Employees: ~17
Development stage: Commercial

Overview

Caprico Biotechnologies provides over 1300 RUO reagents, more than 250 ASR reagents, over 250 monoclonal antibody clones, custom conjugation services, and supports pre-clinical to clinical diagnostic research with cGMP-grade products. Their offerings are widely used in academic research labs as well as CLIA/CAP high-complexity laboratories. No clinical trial results reported since they do not develop drugs.

Therapeutic areas: OncologyImmunologyHematology
Modalities: Monoclonal antibodyAntibody (including fluorescent-conjugated antibodies)Custom conjugatesReagent (for flow cytometry)
Industry: Protein Biomarker Diagnostics

Partnerships

Not specifically listed. Partners with academic labs and diagnostic centers via supply agreements.

Beyond the preview

Go deeper on Caprico Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caprico Biotechnologies.

Explore the full profile